Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Joel Scales Buys 1,906 Shares

Jamieson Wellness Inc. (TSE:JWEL) Senior Officer Joel Scales purchased 1,906 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was acquired at an average cost of C$28.34 per share, with a total value of C$54,016.04.

Jamieson Wellness Trading Down 1.1 %

TSE JWEL traded down C$0.33 during trading on Tuesday, hitting C$28.89. The stock had a trading volume of 26,349 shares, compared to its average volume of 87,868. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76. The stock has a market capitalization of C$1.21 billion, a price-to-earnings ratio of 30.36 and a beta of 0.63. Jamieson Wellness Inc. has a one year low of C$25.42 and a one year high of C$38.20. The stock has a 50 day simple moving average of C$32.29 and a 200 day simple moving average of C$34.06.

Jamieson Wellness Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, March 14th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend was Friday, March 7th. Jamieson Wellness’s dividend payout ratio (DPR) is presently 88.26%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Royal Bank of Canada increased their price target on shares of Jamieson Wellness from C$38.00 to C$41.00 and gave the company an “outperform” rating in a report on Tuesday, February 25th. National Bankshares raised their price objective on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday, November 25th. Finally, BMO Capital Markets raised their price objective on shares of Jamieson Wellness from C$42.00 to C$46.00 in a research note on Thursday, December 19th.

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.